Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
American Journal of Hematology|March 25, 2015
Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND studyRussell K Brynes, Attilio Orazi, Dickens Theodore, et al.Acta Haematologica|December 23, 2016
A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune ThrombocytopeniaRussell K Brynes, Raymond S M Wong, Maung M Thein, et al.Journal of Clinical Gastroenterology|April 25, 2006
Social stigmatization and hepatitis C virus infectionSteven Zacks, Kimberly Beavers, Dickens Theodore, et al.Clinical Pharmacology in Drug Development|February 14, 2025
Lack of Pharmacokinetic Drug-Drug Interactions Between Bepirovirsen and Nucleos(t)ide AnalogsKelong Han, Amir S Youssef, Mindy Magee, et al.Gastro Hep Advances|August 12, 2024
Clinical Consequences of Hepatitis B Surface Antigen Loss in Chronic Hepatitis B Infection: A Systematic Literature Review and Meta-AnalysisEleonora Morais, Lauren Mason, John Dever, et al.Hepatology International|October 3, 2025
Immunomodulation by bepirovirsen may induce killing of infected hepatocytes (B-Together study)Shilpy Joshi, Johannes M Freudenberg, Jennifer M Singh, et al.AIDS (London, England)|September 28, 2002
Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjectsRaymond T Chung, Scott R Evans, Yijun Yang, et al.Journal of Viral Hepatitis|May 16, 2026
Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus InfectionMyriam Drysdale, Rose Chang, Shuang Wang, et al.Clinical Pharmacology in Drug Development|August 16, 2022
Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus-Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple DosesKelong Han, Dickens Theodore, Gina McMullen, et al.CPT: Pharmacometrics & Systems Pharmacology|December 15, 2025
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus InfectionNathan J Hanan, Matthew L Zierhut, Ahmed Nader, et al.Pageof 5